G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2011
05/19/2011	WO2011058137A1 The use of an l3 and/or l5 source as a vaccine or as a diagnostic for a parasitic disease
05/19/2011	WO2011058136A1 Calibration reagent and uses thereof
05/19/2011	WO2011058123A2 Monofilament or multifilament hppe yarns
05/19/2011	WO2011058087A1 Immunoassay for assessing related analytes of different origin
05/19/2011	WO2011058084A1 Biomarkers for predicting rapid response to hcv treatment
05/19/2011	WO2011058080A1 Anti-trypanosomiasis vaccines and diagnostics
05/19/2011	WO2011058055A1 Anti-trypanosome therapeutic and diagnostic applications
05/19/2011	WO2011057826A1 Stabilized open form transglutaminase as a diagnostic indicator for autoimmune diseases
05/19/2011	WO2011057744A1 Differential diagnosis of iron deficiencies based on hepcidin and mean hemoglobin content per reticulocyte
05/19/2011	WO2011057723A1 Method for determining the moisture content in an absorbent sanitary product and device for carrying out the method
05/19/2011	WO2011057683A1 Use of metastasis progressor s100a4 transcripts in body fluids of colorectal and gastric cancer patients
05/19/2011	WO2011057475A1 Test strip for liver screen test based on gold immunochromatographic assay and method of preparing the same
05/19/2011	WO2011057467A1 Nucleic acid chip, preparation method and use thereof
05/19/2011	WO2011057411A1 Ovarian markers of oocyte competency and uses thereof
05/19/2011	WO2011057347A1 Analyte detection
05/19/2011	WO2011036565A3 Device for detecting gases and/or volatile organic compounds (voc)
05/19/2011	WO2011036563A3 Structure of the n-rna complex of the non-segmented negative-strand rna viruses of the paramyxoviridae family
05/19/2011	WO2011035922A3 Inhibitors of fgf2 phosphorylation and their use for treating angiogenesis-related diseases
05/19/2011	WO2011034623A3 Fluorescent dyes and compounds, methods and kits useful for identifying specific organelles and regions in cells of interest
05/19/2011	WO2011033000A3 Sample input device for inputting liquid samples (clot catcher)
05/19/2011	WO2011029607A8 S. aureus allergen
05/19/2011	WO2011028826A3 Reversible current gel electrophoresis device for separating biological macromolecules
05/19/2011	WO2011017564A3 Identification and use of compounds for treating persistent pain
05/19/2011	WO2011017094A3 Assay apparatuses, consumables and methods
05/19/2011	WO2011011527A3 Method and system for automated image analysis in cancer cells
05/19/2011	WO2011008030A3 Chromatographic system for nucleic acid detection
05/19/2011	WO2011007280A3 Measuring molecular contamination in vacuum environments
05/19/2011	WO2010148391A3 Biomarker assay of neurological condition
05/19/2011	WO2010148365A3 Compound arrays for sample profiling
05/19/2011	WO2010148275A3 Bioreactor system
05/19/2011	WO2010147918A3 Detection of acid-producing bacteria
05/19/2011	WO2010133776A3 Device and method for isolating biological or chemical targets
05/19/2011	WO2010111686A3 Labeled enzyme compositions, methods & systems
05/19/2011	WO2010096388A3 Quenched dendrimeric dyes for florescence detection
05/19/2011	WO2010070380A3 Doc1 compositions and methods for treating cancer
05/19/2011	US20110119790 Gene Participating in Low Temperature Germinability in Rice and Utilization of the Same
05/19/2011	US20110119786 Inositol polyphosphate 2-kinase genes and uses thereof
05/19/2011	US20110119776 Methods of diagnosing and prognosing lung cancer
05/19/2011	US20110119087 System for managing treatment of a particular health condition that includes graphing accumulated data
05/19/2011	US20110119086 System for managing treatment of a particular health condition via a mobile phone device
05/19/2011	US20110119074 Pda based system for managing treatment of a patient health condition
05/19/2011	US20110118986 Methods and apparatus for evaluating glucose levels around a repeating event
05/19/2011	US20110118569 Advanced Detection of Sepsis
05/19/2011	US20110118443 Antibody design using anti-lipid antibody crystal structures
05/19/2011	US20110118350 Composition for preventing cardiovascular event in high-risk patient
05/19/2011	US20110118338 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
05/19/2011	US20110118298 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer
05/19/2011	US20110118227 Methods for the Treatment of Fibromyalgia and Chronic Fatigue Syndrome
05/19/2011	US20110118192 Methods and compositions for treating t-cell leukemia
05/19/2011	US20110118181 Pcsk9 inhibitors and methods of use thereof
05/19/2011	US20110118150 Method for making biochips
05/19/2011	US20110118148 Nuclear magnetic resonance assembly of chemical entities using advanced antenna probes
05/19/2011	US20110118140 Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
05/19/2011	US20110118138 Solid phase multi-analyte assay
05/19/2011	US20110118136 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
05/19/2011	US20110118135 Mutations in Contaction Associated Protein 2 (CNTNAP2) are Associated with Increased Risk for Ideopathic Autism
05/19/2011	US20110118129 Method for predicting therapy responsiveness in basal like tumors
05/19/2011	US20110117676 Magnetic sensor, production method of the same, and target substance detecting apparatus and biosensor kit using the same
05/19/2011	US20110117675 Substance immobilizing apparatus, substance detecting apparatus and substance immobilizing method
05/19/2011	US20110117674 Assay method and device
05/19/2011	US20110117673 Methods and systems to collect and prepare samples, to implement, initiate and perform assays, and to control and manage fluid flow
05/19/2011	US20110117672 Magnetic immunochromatographic test method and device
05/19/2011	US20110117671 Method for Stabilizing Microparticles Having Reactive Substance Bound Thereto, and Reagent Containing the Microparticles
05/19/2011	US20110117670 Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms
05/19/2011	US20110117669 Materials and methods for detecting toxins, pathogens and other biological materials
05/19/2011	US20110117663 Use of a fabric comprising a specific material for detecting the presence of a chemical substance
05/19/2011	US20110117661 Polypeptides, systems, and methods useful for detecting glucose
05/19/2011	US20110117660 Physical characterization of oligonucleotide conjugates
05/19/2011	US20110117659 Quinazoline-containing kits for labeling aldehyde or ketone moieties
05/19/2011	US20110117658 Method of rational-based drug design using osteocalcin
05/19/2011	US20110117657 Selective and sensitive detection of mercuric ion by novel dansyl-appended calix[4]arene molecules, via fluorescence quenching
05/19/2011	US20110117654 Buffer solution for electroporation and a method comprising the use of the same
05/19/2011	US20110117644 DR5 gene promoter and SIAH-1 gene promoter
05/19/2011	US20110117589 Use of procalcitonin (pct) in prognosis following acute coronary syndromes
05/19/2011	US20110117585 Quantitative multiplex detection of pathogen biomarkers
05/19/2011	US20110117584 Detection of Chronic Kidney Disease Patients or Coronary Artery Disease Using Bone Morphogenic Protein-4
05/19/2011	US20110117583 Method for detecting the existence of renal calculi and/or inflammation of the excretory urinary tracts
05/19/2011	US20110117582 Multi-biomarker biosensor
05/19/2011	US20110117581 Reducing leukocyte interference in competitive immunoassays
05/19/2011	US20110117580 Reducing leukocyte interference in non-competitive immunoassays
05/19/2011	US20110117579 System and Method for Quantitative Assessment of Biological Migration Behavior
05/19/2011	US20110117578 Biomarker for selecting patients and related methods
05/19/2011	US20110117577 Microfluidic system for trapping and detection of a biological entity in a sample
05/19/2011	US20110117576 Mct-1, a human oncogene
05/19/2011	US20110117575 Isolation and/or identification of stem cells having adipocytic, chondrocytic and pancreatic differentiation potential
05/19/2011	US20110117574 Fluorescence based assay to detect sodium/calcium exchanger "forward mode" modulating compounds
05/19/2011	US20110117573 Cell division marker
05/19/2011	US20110117572 Antibody Specific to the AIMP2-DX2
05/19/2011	US20110117571 Transporter assay
05/19/2011	US20110117569 Polymide nucleic acid derivatives, and agents and processes for preparing them
05/19/2011	US20110117566 Model System for Diagnosing Lipid Metabolism
05/19/2011	US20110117558 Diagnosis of hereditary spastic paraplegias (hsp) by identification of a mutation in the zfyve26 gene or protein
05/19/2011	US20110117557 Methods and Compositions For Diagnosis of Age-Related Macular Degeneration
05/19/2011	US20110117556 High-sensitive fluorescent energy transfer assay using fluorescent amino acids and fluoresent proteins
05/19/2011	US20110117555 CD38 as a prognostic indicator in chronic lymphocytic leukemia
05/19/2011	US20110117551 Detection and prognosis of lung cancer
05/19/2011	US20110117549 Method for detecting nucleic acid, and device or kit
05/19/2011	US20110117539 Detection of an Analyte in a Sample
05/19/2011	US20110117204 Immunologically active compositions
05/19/2011	US20110117130 Method of diagnosing and treating Ehrlichia

1 ... 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 ... 3937